Zirgan (ganciclovir ophthalmic gel) 0.15%


ZIRGAN is indicated for the treatment of eye ulcers caused by a herpes virus.


  • ZIRGAN is indicated for topical ophthalmic use in the eye only.

  • Patients should not wear contact lenses if they have signs or symptoms of eye infections while using ZIRGAN.

  • The most common side effects reported in patients were blurred vision, eye irritation, eye redness and punctate keratitis (a specific type of eye surface irritation).

  • Safety and efficacy in children below the age of 2 years have not been established.

  • Patients should consult their doctor if they experience pain, redness, itching, or swelling of the eye when using ZIRGAN.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call

To contact Bausch + Lomb, call 1-800-323-0000 or visit www.bausch.com.

Click here for Prescribing Information about ZIRGAN.

Reference: 1. Foster CS. Ganciclovir gel—a new topical treatment for herpetic keratitis. US Ophthalmic Rev. 2008;3(1):52-56.